This вЂњreclassificationвЂќ of CVR is based on three basically sound ideas: first, use of just the four risk factors (RF) with the most weight as recognized in cardiovascular epidemiology: cholesterol, blood pressure (BP), diabetes mellitus and smoking second, from the practical viewpoint, the physician is interested in determining the overall CVR, and the model therefore includes the prediction of all CVD events, providing calibration factors for each entity that may be of interest to the physician and third, inclusion of the concept of vascular age or heart age, and which can be calculated from the model. The Framingham-Study researchers have therefore proposed a new model for use in the primary care setting, patently differentiated by gender. Several scoring systems exist to help clinicians assess the 10-year CHD risk with the Framingham risk score the most widely used. Guidelines for the prevention of CVD recommend the use of risk scores to identify adults at higher risk of CVD for whom preventive therapy has higher absolute benefits. However, the situation in primary care is not the same, particularly concerning the choice of methods for calculating or classifying cardiovascular risk (CVR). In addition, firm evidence supports the effectiveness of secondary prevention and there is almost unanimous agreement on its management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Д¬ompeting interests: The authors have declared that no competing interests exist.Д¬ardiovascular diseases (CVD) are widely accepted to be the most serious health care problem in both developed countries. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ДЇunding: This study was supported by two grants from Junta de Comunidades Castilla-La Mancha, ConsejerГa de Sanidad, Spain (Orden 3 July 1992 del DOCM and Orden 14 September 1993 del DOCM), and funding from FISCAM Project 2003-2006 (03069-00) of Junta de Comunidades de Castilla-La Mancha, Spain (ALM, MD PhD, Principal Investigator). Received: MaAccepted: JPublished: September 5, 2013Д¬opyright: В© 2013 Artigao-Rodenas et al. PLoS ONE 8(9):Д®ditor: Yiqing Song, Brigham & Women's Hospital, and Harvard Medical School, United States of America (2013) Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe. Citation: Artigao-Rodenas LM, Carbayo-Herencia JA, DivisГіn-Garrote JA, Gil-GuillГ©n VF, MassГі-Orozco J, Simarro-Rueda M, et al.

Framingham risk score guidelines